[PDF][PDF] An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors
…, C Radziejewski, E Campbell, L Kovac, M McGlynn… - Molecular cell, 1997 - cell.com
Mammalian cells constantly monitor and respond to a myriad of extracellular signals, often
by using cell surface receptors. Two important classes of cell surface receptors include the …
by using cell surface receptors. Two important classes of cell surface receptors include the …
[PDF][PDF] An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates
…, A Ryan, DT Kobayashi, R Chauhan, M McGlynn… - Cell host & …, 2021 - cell.com
The SARS-CoV-2 pandemic has affected more than 185 million people worldwide resulting
in over 4 million deaths. To contain the pandemic, there is a continued need for safe …
in over 4 million deaths. To contain the pandemic, there is a continued need for safe …
Immunogenicity of an AAV-based, room-temperature stable, single dose COVID-19 vaccine in mouse and non-human primates
…, A Ryan, DT Kobayashi, R Chauhan, M McGlynn… - bioRxiv, 2021 - biorxiv.org
The SARS-CoV-2 pandemic has affected more than 70 million people worldwide and resulted
in over 1.5 million deaths. A broad deployment of effective immunization campaigns to …
in over 1.5 million deaths. A broad deployment of effective immunization campaigns to …
Genetic analysis suggests functional interactions between the N-and C-terminal domains of the TetA (C) efflux pump encoded by pBR322
P McNicholas, M McGlynn, GG Guay… - Journal of …, 1995 - Am Soc Microbiol
Genetic analysis of the tetA(C) gene of pBR322 indicates the importance of two-cytoplasmic
loops in the TetA(C) protein (P. McNicholas, I. Chopra, and DM Rothstein, J. Bacteriol. 174:…
loops in the TetA(C) protein (P. McNicholas, I. Chopra, and DM Rothstein, J. Bacteriol. 174:…
The performance of three fitting criteria for multidimensional scaling
M McGlynn - 1990 - escholarship.mcgill.ca
A Monte Carlo study was performed to investigate the ability of MSCAL to recover by
Euclidean metric multidimensional scal~ ng (MDS) the true structure for dissimilarity data with …
Euclidean metric multidimensional scal~ ng (MDS) the true structure for dissimilarity data with …
Molecular Mechanism of the N501Y Mutation for Enhanced Binding between SARS-CoV-2's Spike Protein and Human ACE2 Receptor (preprint)
…, A Ryan, DT Kobayashi, R Chauhan, M McGlynn… - 2021 - pesquisa.bvsalud.org
Coronavirus disease 2019 (COVID-19) has been an ongoing global pandemic for over one
year. Recently, an emergent SARS-CoV-2 variant (B. 1.1. 7) with an unusually large number …
year. Recently, an emergent SARS-CoV-2 variant (B. 1.1. 7) with an unusually large number …
Detection of tetracyclines and efflux pump inhibitors
DM Rothstein, M McGlynn, V Bernan… - Antimicrobial agents …, 1993 - Am Soc Microbiol
Screening assays for the detection of tetracyclines and inhibitors of tetracycline efflux pumps
are described. The tetracycline assay is based on the observation that the tetA(B) gene …
are described. The tetracycline assay is based on the observation that the tetA(B) gene …
Immunogenicity of an AAV-based, room-temperature stable, single dose COVID-19 vaccine in mice and non-human primates (preprint)
…, A Ryan, DT Kobayashi, R Chauhan, M McGlynn… - 2021 - pesquisa.bvsalud.org
The SARS-CoV-2 pandemic has affected more than 70 million people worldwide and resulted
in over 1.5 million deaths. A broad deployment of effective immunization campaigns to …
in over 1.5 million deaths. A broad deployment of effective immunization campaigns to …
[HTML][HTML] Exploring public attitudes towards approaches to discussing costs in the clinical encounter
…, S Chen, S Goold, S Pearson, E McGlynn - Journal of general …, 2014 - Springer
BACKGROUND Patients’ willingness to discuss costs of treatment alternatives with their
physicians is uncertain. OBJECTIVE To explore public attitudes toward doctor–patient …
physicians is uncertain. OBJECTIVE To explore public attitudes toward doctor–patient …
Late effects in survivors of post‐transplant lymphoproliferative disease
MC McGlynn, K Brady, JM Healey… - Pediatric Blood & …, 2024 - Wiley Online Library
Background Treatment of post‐transplant lymphoproliferative disease (PTLD) varies, with
only some patients receiving chemotherapy. Concern for chemotherapy toxicities may …
only some patients receiving chemotherapy. Concern for chemotherapy toxicities may …